179 related articles for article (PubMed ID: 11713447)
1. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
[TBL] [Abstract][Full Text] [Related]
2. Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter.
O'Sullivan GJ; Lohan DG; Gough N; Cronin CG; Kee ST
J Vasc Interv Radiol; 2007 Jun; 18(6):715-24. PubMed ID: 17538133
[TBL] [Abstract][Full Text] [Related]
3. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
[TBL] [Abstract][Full Text] [Related]
4. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
[TBL] [Abstract][Full Text] [Related]
5. Assessing the outcome of systemic tissue plasminogen activator for the management of venous and arterial thrombosis in pediatrics.
Newall F; Browne M; Savoia H; Campbell J; Barnes C; Monagle P
J Pediatr Hematol Oncol; 2007 Apr; 29(4):269-73. PubMed ID: 17414572
[TBL] [Abstract][Full Text] [Related]
6. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
Skeik N; Gits CC; Ehrenwald E; Cragg AH
Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis for intravascular thrombosis in neonates and children.
Raffini L
Curr Opin Pediatr; 2009 Feb; 21(1):9-14. PubMed ID: 19242237
[TBL] [Abstract][Full Text] [Related]
10. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
12. Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: a single center experience.
Bratincsák A; Moore JW; El-Said HG
Catheter Cardiovasc Interv; 2013 Nov; 82(5):782-5. PubMed ID: 22718305
[TBL] [Abstract][Full Text] [Related]
13. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
14. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
Marder VJ
Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis.
Matosevic B; Knoflach M; Werner P; Pechlaner R; Zangerle A; Ruecker M; Kirchmayr M; Willeit J; Kiechl S
Neurology; 2013 Mar; 80(13):1216-24. PubMed ID: 23486872
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator.
Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G
Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients.
Ray TL; Berkenbosch JW; Russo P; Tobias JD
J Intensive Care Med; 2004; 19(1):44-50. PubMed ID: 15035754
[TBL] [Abstract][Full Text] [Related]
18. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
[TBL] [Abstract][Full Text] [Related]
19. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
20. Tissue Plasminogen Activator Use in Children: Bleeding Complications and Thrombus Resolution.
Ansah DA; Patel KN; Montegna L; Nicholson GT; Ehrlich AC; Petit CJ
J Pediatr; 2016 Apr; 171():67-72.e1-2. PubMed ID: 26707578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
